ttopstart academy - getting nih funding as a european researcher or company

17
Webinar Opportunities for orphan drug development in Horizon 2020 © ttopstart BV www.ttopstart.com [email protected] How to get NIH funding as a non-US entity ttopstart academy January 2016 Ferdinand Los, PhD – consultant @ ttopstart

Upload: ttopstart-bv

Post on 09-Jan-2017

1.129 views

Category:

Science


0 download

TRANSCRIPT

Page 1: ttopstart academy - getting NIH funding as a European researcher or company

• Webinar• Opportunities for orphan drug

development in Horizon 2020© ttopstart [email protected]

How to get NIH funding as a non-US entity

ttopstart academy

January 2016

Ferdinand Los, PhD – consultant @ ttopstart

Page 2: ttopstart academy - getting NIH funding as a European researcher or company

For every € 100 from Horizon 2020 for life sciencesthe NIH spends another $ 15 in Europe

$$

This is a guide to NIH grants for non-US entities

Page 3: ttopstart academy - getting NIH funding as a European researcher or company

Empowering biomedical researchers andentrepreneurs to establish breakthroughs

Page 4: ttopstart academy - getting NIH funding as a European researcher or company

The National Institutes of Health (NIH) is the primary U.S. agency

responsible for biomedical and health-related research. The NIH provides

major research funding to non-NIH research facilities, including foreign

institutions and international organisations.

The NIH research budget in 2014 was $24B, approximately $1.3B is spent

outside the US and of that, $175M in Europe.

This presentation aims to guide non-US entities to NIH funding:

• How to determine whether you meet the requirements for eligibility

• How to identify which type of NIH grant fits you best

• Where to search for Funding Opportunity Announcements (FOAs) and

specific topics that match your envisioned project

Introduction

NIH

Page 5: ttopstart academy - getting NIH funding as a European researcher or company

In general,

• eligible institutions can be higher education, government, non-profitand for-profit organisations and institutions.

The NIH usually accepts applications both by individual researchers andby research consortia, for all types of programs and calls.

General criteria on eligibility are provided in sections III.1.A and III.1.B ofeach FOA, describing the suitable type of institutions or individuals

General requirements for applicants

NIH

Page 6: ttopstart academy - getting NIH funding as a European researcher or company

For non-US applicants the following will be assessed:

• Does the project employ unusual talents, resources, populations, orenvironmental conditions that are not readily available in the U.S.that either facilitate further research or augment existing resources?

• Is the proposed project specifically relevant to the mission andobjectives of the NIH and does it have the potential to significantlyadvance health sciences in the U.S?

Additional information on the requirements for non-US applicants maybe found here.

Specific requirements for non-US applicants

NIH

Page 7: ttopstart academy - getting NIH funding as a European researcher or company

Types of NIH programs

NIH

R01 specified research project 3-5 years No set budget, typically

$250k a year

R03 limited funding for a short period 2 years $50k a year

R21 early stage research 2 years $275k total

R34 phase III clinical trials 1 year $100k

U01 specified research project, by

investigator(s) in their specific area of

interest and competencies

No set budget

P01 multi-project research projects No set budget

The NIH accepts both unsolicited grant applications as well as responsesto specific calls. Unsolicited programs are investigator-initiated andbottom-up, open to any kind of project. For both types of applications,the NIH has a number of grant programs or instruments. Non-US entitiesare eligible to apply for a subset of these:

Page 8: ttopstart academy - getting NIH funding as a European researcher or company

• R01 - discrete, specified, circumscribed research projects

• R03 - limited funding for a short period, including: pilot or feasibilitystudies, collection of preliminary data, secondary analysis of existingdata, small, self-contained research projects, development of newresearch technology, etc.

• R21 - exploratory and developmental research projects

• R34 - phase III clinical trials

• U01 - discrete and specified research projects, to be performed byinvestigator(s) in their specific area of interest and competencies

• P01 - integrated, multi-project research projects involving differentindependent investigators. Open to non-US applicants under specificconditions, mentioned in FOAs

Types of NIH programs

NIH

Page 9: ttopstart academy - getting NIH funding as a European researcher or company

NIH is made up of 27 Institutes and Centers, each with a specificresearch agenda, often focusing on particular diseases or body systems.Based on the research topic, the grant application is send to one of theseinstitutes. For instance the:

• National Cancer Institute (NCI)

• National Institute on Aging (NIA)

• National Institute of Allergy andInfectious Diseases (NIAID)

NIH institutions

NIH

Page 10: ttopstart academy - getting NIH funding as a European researcher or company

Open calls can be found through different means:

• For unsolicited grant applications there are so-called parent FOAs.

• All U.S. grants are published through this website.

• Relevant NIH-calls can also be found in the ttopstart database, listedby topic.

Certain FOAs describe specific objectives and expected outcomes. Inother cases, there are no specific program requirements, but theproposed research plan must be related to the stated program interestsof one or more of the 27 NIH Institutes and Centers.

Specifics and exceptions are found in the FOA descriptions.

Funding Opportunity Announcements and specific topics

NIH

Page 11: ttopstart academy - getting NIH funding as a European researcher or company

Generally, NIH grants cycle through three annual deadlines, details ofwhich may be found here. For the relevant programs, the deadlines areoutlined below.

Submission deadlines

NIH

R01, U01 February 5 June 5 October 5

R03, R21, R34 February 16 June 16 October 16

P01 January 25 May 25 September 25

Page 12: ttopstart academy - getting NIH funding as a European researcher or company

[email protected]

or check our dedicated NIH page

Page 13: ttopstart academy - getting NIH funding as a European researcher or company

The ttopstart team

NIH

Page 14: ttopstart academy - getting NIH funding as a European researcher or company

ttopstart is a science and business consulting company thatserves leading researchers and innovative companies in thefields of life sciences and medical technology.

Our excellent track-record is attributable to:

• Our broad technological and scientific knowledge

• Our business development background

• Our in-depth knowledge of subsidy programmes

• Our structured approach

• Our writing skills

About ttopstart

NIH

Page 15: ttopstart academy - getting NIH funding as a European researcher or company

ttopstart offers a balanced set of funding and business development services, all dedicated to biomedicalresearchers and entrepreneurs.

ttopstart services

NIH

Prepare

Funding strategy

Develop

Proposal writing

PRO-ACTIV• Analysis• Customised strategy• Training & Implementation• Valuation

FFWD• Fit• Framework • Write • Develop

Empower your team to excel Reach a 50% success rate

Execute

Project management

• Management• Dissemination• Exploitation

Focus on the science

Exploit

Business development

Page 16: ttopstart academy - getting NIH funding as a European researcher or company

Check our funding database:

www.ttopstart.com/subsidies/database

Page 17: ttopstart academy - getting NIH funding as a European researcher or company

ttopstart BV

[email protected]

P.C. Staalweg 303721 TJ BilthovenThe Netherlands+31 (0)30 73 70 779

Our services• Subsidies• Business development• Project managementFor life sciences and medical technology

The ttopstart team:Patrick de Boer, MScJochem Bossenbroek, MScir. Jasper LevinkSanne Kuijper, PhDMarije aan den Toorn, PhDFerdinand Los, PhDJean-Pierre Sommeijer, PhDMichelle van Wijk, MScAndrée Schram, PhDGeorgia Xouri, PhDAntoin de Weijer, PhDKarlijn Bastiaansen, PhDKarin Bosch-Elberse, PhDJelle Zijlstra, MScAnouk IJlst, MA